246 related articles for article (PubMed ID: 26056182)
1. R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability.
Chen HY; Yu SL; Ho BC; Su KY; Hsu YC; Chang CS; Li YC; Yang SY; Hsu PY; Ho H; Chang YH; Chen CY; Yang HI; Hsu CP; Yang TY; Chen KC; Hsu KH; Tseng JS; Hsia JY; Chuang CY; Yuan S; Lee MH; Liu CH; Wu GI; Hsiung CA; Chen YM; Wang CL; Huang MS; Yu CJ; Chen KY; Tsai YH; Su WC; Chen HW; Chen JJ; Chen CJ; Chang GC; Yang PC; Li KC
J Clin Oncol; 2015 Jul; 33(20):2303-10. PubMed ID: 26056182
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
[TBL] [Abstract][Full Text] [Related]
3. Two germline mutations can serve as genetic susceptibility screening makers for a lung adenocarcinoma family.
Xiao N; Cao X; Liu Z; Han Y
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6541-6548. PubMed ID: 36781503
[TBL] [Abstract][Full Text] [Related]
4. YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment.
Pan D
J Clin Oncol; 2015 Jul; 33(20):2311-3. PubMed ID: 26056180
[No Abstract] [Full Text] [Related]
5. Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients.
Hsu KH; Tseng JS; Wang CL; Yang TY; Tseng CH; Chen HY; Chen KC; Tsai CR; Yang CT; Yu SL; Su KY; Yu CJ; Ho CC; Hsia TC; Wu MF; Chiu KL; Liu CM; Yang PC; Chen JJ; Chang GC
Oncotarget; 2016 Aug; 7(33):53299-53308. PubMed ID: 27449093
[TBL] [Abstract][Full Text] [Related]
6. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
[TBL] [Abstract][Full Text] [Related]
8. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.
Wu C; Xu B; Yuan P; Miao X; Liu Y; Guan Y; Yu D; Xu J; Zhang T; Shen H; Wu T; Lin D
Cancer Res; 2010 Dec; 70(23):9721-9. PubMed ID: 21118971
[TBL] [Abstract][Full Text] [Related]
10. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
[TBL] [Abstract][Full Text] [Related]
12. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
13. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Chaib I; Karachaliou N; Pilotto S; Codony Servat J; Cai X; Li X; Drozdowskyj A; Servat CC; Yang J; Hu C; Cardona AF; Vivanco GL; Vergnenegre A; Sanchez JM; Provencio M; de Marinis F; Passaro A; Carcereny E; Reguart N; Campelo CG; Teixido C; Sperduti I; Rodriguez S; Lazzari C; Verlicchi A; de Aguirre I; Queralt C; Wei J; Estrada R; Puig de la Bellacasa R; Ramirez JL; Jacobson K; Ditzel HJ; Santarpia M; Viteri S; Molina MA; Zhou C; Cao P; Ma PC; Bivona TG; Rosell R
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376152
[TBL] [Abstract][Full Text] [Related]
14. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
[TBL] [Abstract][Full Text] [Related]
16. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.
Matsuguma H; Yokoi K; Anraku M; Kondo T; Kamiyama Y; Mori K; Tominaga K; Tsuura Y; Honjo S
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):278-84. PubMed ID: 12167787
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report.
Yu X; Sheng D; Jiang J; Ren M; Jin M; Xu S
Int J Clin Exp Pathol; 2015; 8(7):8579-84. PubMed ID: 26339437
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
Tode N; Kikuchi T; Sakakibara T; Hirano T; Inoue A; Ohkouchi S; Tamada T; Okazaki T; Koarai A; Sugiura H; Niihori T; Aoki Y; Nakayama K; Matsumoto K; Matsubara Y; Yamamoto M; Watanabe A; Nukiwa T; Ichinose M
Cancer Sci; 2017 Jun; 108(6):1263-1270. PubMed ID: 28294470
[TBL] [Abstract][Full Text] [Related]
19. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
20. Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.
Hastings R; de Villiers CP; Hooper C; Ormondroyd L; Pagnamenta A; Lise S; Salatino S; Knight SJ; Taylor JC; Thomson KL; Arnold L; Chatziefthimiou SD; Konarev PV; Wilmanns M; Ehler E; Ghisleni A; Gautel M; Blair E; Watkins H; Gehmlich K
Circ Cardiovasc Genet; 2016 Oct; 9(5):426-435. PubMed ID: 27625337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
